Scheme 1. Solid-Supported Synthesis of Libraries 1 and 2a
Figure 1. (a) Mannose and fucose residues participate in binding
to C-type lectins via their axial-equatorial-equatorial vicinal
hydroxyl group. (b) Transformation of shikimic acid affords
products with the desired hydroxyl group arrangement.
a Conditions: (a) FMOC-(R1)-OH, HBTU, DIEA, DMF; (b)
piperidine, DMF; (c) shikimic acid, DIC, C6F5OH, HOBt, DMF;
(d) R2SH, KOt-Bu, t-BuOH, DMF; (e) TFA, Et3SiH, H2O,
HSCH2CH2SH; (f) HS-R3-SH, KOt-Bu, t-BuOH, DMF; (g) R4-Br,
KI, Et3N, DMF; (h) TFA, H2O.
ligands that target a range of lectins within the C-type lectin
superfamily. A key criterion for our scaffold was that it
should allow for the streamlined synthesis of libraries.8
We chose to build our library from the carbocycle shikimic
acid. Shikimic acid possesses three hydroxyl groups that are
displayed in a pseudoaxial-pseudoequatorial-pseudoequa-
torial configuration (Figure 1B). We envisioned that glyco-
mimetics could be generated by the stereoselective conjugate
addition of nucleophiles. Diversification could be achieved
by using different thiol building blocks and by elaboration
of the carboxylic acid. We chose to use thiolates as building
blocks because they are excellent nucleophiles, and the
corresponding conjugate addition reactions should proceed
under mild conditions. With proper stereochemical control,
conjugate addition could provide the requisite axial-
equatorial-equatorial display of vicinal hydroxyl groups
(Figure 1B).9 Multivalent derivatives of shikimic acid itself
have been used previously to inhibit a protein-carbohydrate
interaction.10 Because of the mode of C-type lectin ligand
binding, we surmised that the proposed transformations of
shikimic acid would yield more potent ligands.
the incoming nucleophile would approach the unsaturated
carbonyl compound on the si face opposite the allylic
hydroxyl group. The stereochemical outcome from proto-
nation of the incipient enolate, however, was more difficult
to predict. We found that when the addition was conducted
using a shikimic acid derivative with free hydroxyl groups,
the desired isomer was obtained. Under the optimized
conditions, thiolate addition occurs from the si face, followed
by axial protonation to afford the desired isomer (Figure 2).
With this knowledge, we set about to develop solid-phase
routes to the target compounds.
Figure 2. Desired stereochemical outcome was obtained from
thiolate conjugate addition to shikimic acid methyl ester. Protonation
of the incipient enolate on the other face affords a product that
would exist in a conformer in which the hydroxyl groups are
improperly oriented for C-type lectin binding.
To facilitate preparation of glycomimetic libraries, two
related solid-phase, parallel syntheses were envisioned
(Scheme 1). The key step in each strategy, the conjugate
addition of a thiolate to a shikimic acid derivative, was tested
in solution. At issue was the stereochemical outcome of the
conjugate addition reaction. Specifically, we anticipated that
In both of the synthetic routes developed, Rink amide
4-methylbenzhydrylamine polystyrene resin was utilized as
the synthetic support. It is stable toward a variety of reaction
conditions and delivers compounds with terminal amide
groups.11 To the immobilized amine was coupled either one
or two commercially available amino acids via standard
methods. Shikimic acid, which could be obtained via
fermentation12 or isolated from star anise, was then coupled
to the free N-terminal amine.13 Conveniently, shikimic acid
could be added without protection of its secondary hydroxyl
(8) (a) Bianco, A.; Brufani, M.; Manna, F.; Melchioni, C. Carbohydr.
Res. 2001, 332, 23-31. (b) Kim, C. U.; Lew, W.; Williams, M. A.; Liu,
H.; Zhang, L.; Swaminathan, S.; Bischofberger, N.; Chen, M. S.; Mendal,
D. B.; Tai, C. Y.; Laver, W. G.; Stevens, R. C. J. Am. Chem. Soc. 1997,
119, 681-690. (c) Kim, C. U.; Lew, W.; Williams, M. A.; Wu, H. W.;
Zhang, L. J.; Chen, X. W.; Escarpe, P. A.; Mendel, D. B.; Laver, W. G.;
Stevens, R. C. J. Med. Chem. 1998, 41, 2451-2460. (d) Lew, W.; Wu, H.
W.; Mendel, D. B.; Escarpe, P. A.; Chen, X. W.; Laver, W. G.; Graves, B.
J.; Kim, C. U. Bioorg. Med. Chem. Lett. 1998, 8, 3321-3324. (e) Williams,
M. A.; Lew, W.; Mendel, D. B.; Tai, C. Y.; Escarpe, P. A.; Laver, W. G.;
Stevens, R. C.; Kim, C. U. Bioorg. Med. Chem. Lett. 1997, 7, 1837-1842.
(9) Rich, R. H.; Lawrence, B. M.; Bartlett, P. A. J. Org. Chem. 1994,
59, 693-694.
(10) (a) Grandjean, C.; Rommens, C.; Gras-Masse, H.; Melnyk, O. J.
Chem. Soc., Perkin Trans. 1 1999, 2967-2975. (b) Grandjean, C.;
Angyalosi, G.; Loing, E.; Adriaenssens, E.; Melnyk, O.; Pancre, V.; Auriault,
C.; Gras-Masse, H. Chembiochem 2001, 2, 747-757.
(11) (a) Santini, R.; Griffith, M. C.; Qi, M. Tetrahedron Lett. 1998, 39,
8951-8954. (b) Adams, J. H.; Cook, R. M.; Hudson, D.; Jammalamadaka,
V.; Lyttle, M. H.; Songster, M. F. J. Org. Chem. 1998, 63, 3706-3716.
1408
Org. Lett., Vol. 5, No. 9, 2003